Value of 99mtc-methoxyisobutylisonitrile (99mtc-mibi) gated spect for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results

Nuclear Medicine Communications

Volumn 27, Issue 1, 2006, Pages 61-69

  Caglar, Meltem ^a   Mahmoudian, Babak ^a   Aytemir, Kudret ^a   Kahraman, Serkan ^a   Kabakc, Giray ^a   Karabulut, Erdem ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Hemodialysis; Myocardial perfusion scintigraphy; Silent ischemia

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CREATININE; ELECTROLYTE; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GATED IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FOLLOW UP; HEART FUNCTION TEST; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEMODIALYSIS; LABORATORY TEST; SILENT MYOCARDIAL INFARCTION;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; RADIOPHARMACEUTICALS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645235889     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200601000-00010     Document Type: Article

References (34)

1. Annual Data Report V. Patient mortality and survival. Am J Kidney Dis 1998; 32 (Suppl 1):S69-S80.
2. Degoulet P, Legrain M, Aime F, Derries C, Rojas P, Jacobs C. Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982; 31:103-110.
3. Linder A, Chara B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697-701.
4. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10:1606-1615.
5. Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol 1991; 2:2-12.
6. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97:138-141.
7. Zuber M, Steinmann E, Hurser B, Ritz R, Thiel G, Brunner F. Incidence of arrhythmias and myocardial ischemia during haemodialysis and haemofiltration. Nephrol Dial Transplant 1989; 4:632-634.
8. Hadj-Abdelkader M, Rozand JY, Alphonse JC, Guret C, Deteix P. Use of stress echocardiography in detecting silent myocardial ischemia in hemodialysis patients. Arch Mal Coeur Vaiss 2003; 95:735-737.
9. Penfornis A, Zimmermann C, Boumal D. Use of dobutamine stress echocardiography in detecting silent myocardial ischemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 2001; 18:900-905.
10. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27:1954-1961.
11. Blumenenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, et al. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 2003; 107:702-707.
12. Chaitman BR. Exercise stress testing. In: Braunwald E (editor): Heart disease. 6th ed. Pennsylvania: W.B. Saunders; 2001, pp. 129-152.
13. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzani M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36:2138-2147.
14. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004; 11:171-185.
15. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med 2003; 31:261-291.
16. Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine Tc-99m-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 2003; 44:134-139.
17. Annuk M, Zilmer M, Fellstrom B. Endothelium-dependent vasodilatation and oxidative stress in chronic renal failure: impact on cardiovascular disease. Kidney Int Suppl 2003; 84:S50-S53.
18. Narita M, Kuhira T. Scintigraphic assessment of patients with electrocardiographic left ventricular hypertrophy with ST-T changes without apparent cause. Clin Nucl Med 2002; 27:641-647.
19. Wieneke H, Zander C, Eising EG, Haude M, Bockisch A, Erbel R. Non-invasive characterisation of cardiac microvascular disease by nuclear medicine single photon emission tomography. Herz 1999; 24:515-521.
20. Iriarte M, Caso R, Murga N. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of Thallium-201 scintigraphy. Am J Cardiol 1995; 75:335-339.
21. Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002; 105:470-476.
22. Fragasso G. Diagnosing coronary artery disease in patients with hypertension: a resolved dilemma? Ital Heart J 2000; 1:726-731.
23. Verna E, Ceriani L, Giovanella L, Binaghi G, Garancini S. ‘False-positive’ myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonographic studies. J Nucl Med 2000; 41:1935-1940.
24. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R. Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991; 36:192-202.
25. Feola M, Biggi A, Ribichini F, Rovere A, Vado A, Camuzzini G, et al. Predicting cardiac events with Tl201 dipyridamole myocardial scintigraphy in renal transplant recipients. J Nephrol 2002; 15:48-53.
26. Miyao Y, Miyazaki S, Goto Y, Itoh A, Daikoku S, Morii I, et al. Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction. Jpn Circ J 1999; 63:362-366.
27. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
28. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169:203-214.
29. Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl 1993; 41:S72-S77.
30. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. Clin Invest 1986; 77:1370-1376.
31. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1996; 98:5-7.
32. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91:6369-6373.
33. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95:1119-1121.
34. Denker BM, Chertow GM, Owen WF. Hemodialysis. In: Brenner BM (editor): The kidney. 6th ed. Pennsylvania: W.B. Saunders; 2000, pp. 2373-2453.